Chippenham, UK - 6 August 2010: Vectura Group plc (LSE: VEC) ("Vectura") announces that Glaxo Group Limited and GlaxoSmithKline Research & Development Limited ("GSK") have signed a worldwide ...
AUSTIN, Texas--(BUSINESS WIRE)--TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its ...
LEXINGTON, Mass.--Pulmatrix, a biotechnology company developing breakthrough therapies for respiratory diseases, today announced that its iSPERSE™ inhaled drug delivery platform demonstrated the ...
11th November 2014. Boston, MA, USA. DoseOne, LLC holds multiple patents and prepared to partner the most innovative DPIs available today, the DoseOne™ Single Dose Powder Inhaler. Development of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback